Table of Contents Table of Contents
Previous Page  686 / 1084 Next Page
Information
Show Menu
Previous Page 686 / 1084 Next Page
Page Background

We performed a retrospective cohort study of patients with

Stage IB–IV (M0) gastric adenocarcinoma

who underwent resection

from 1991 to 2009

using the linked

SEER–Medicare database

Only 19.1% of patients received post

operative

chemoradiation therapy (CRT), and

1.9% received

peri

operative chemotherapy

; most patients underwent

surgery alone (60.9%)

The proportion of patients treated with postoperative

CRT increased significantly after trial publication as did the

proportion of patients treated with peri operative

chemotherapy

There are a number of

hypotheses that might explain

the undertreatment of gastric cancer patients despite high

quality evidence supporting its use:

timeliness of information dissemination

economic impact of treatment

availability of resources and multidisciplinary expertise

03/27/2017